Medical Account Specialist II- Hematology
Regeneron Pharmaceuticals
Summary
The Hematology Oncology Account Specialist is responsible for engaging Oncology specialists and other key Oncology customers within a geographical universe and settings, including academic centers, large group practices, IDNs, and community accounts in support of the launch of our Multiple Myeloma product. This key role will focus on presenting clinically focused selling messages to build and grow revenue and to consistently deliver product goals.
Job description
Discover your role
- Engage Oncology Experts and other key Oncology customers within the assigned geographical locations. Deliver clinically focused selling messages to support the launch of a bi-specific agent to treat malignancies in MM, respectively, to grow brand share and revenue and to deliver product goals.
- Facilitate partnership with multiple collaboration partners; Regional Director, Territory-based Oncology Account Specialists, Reimbursement Specialists to proactively resolve customer needs, identify market dynamics and trends, and develop strategies which support brand and corporate objectives in assigned territory.
- Develop strong working relationships with aligned designated accounts and specialists
- Execute market profiling activities to ensure a deep understanding of regional and local health care delivery, influencers and payer systems.
- Proactively identify business opportunities with assigned accounts and leads to appropriate coordination of effort by the Regeneron Oncology account team, e.g. supports contracting pull-through with accounts.
- Develop a breadth of relationships within each account to ensure an understanding of each account’s objectives, goals, and challenges and identify approved Regeneron Oncology resources that are aligned to the customer’s needs.
- Demonstrate dedication to compliance through understanding regulations and policies that govern customer interactions and consistent focus on ensuring compliance with them.
This role might be for you if
- You have proven sophisticated clinically based and account-based selling skills
- You have shown success and positive consistent sales performance in complex markets with diverse customer segments operating with a high degree of integrity within compliance guidelines
- You are results-oriented with a track record of success with product launches
- You are a strong account manager with analytical, problem-solving and planning skills
Requirements
- Bachelor's degree
- Minimum of 5 years successful experience in Oncology sales
- Hematology Oncology preferred
- Buy and bill experience with biologics required
- Minimum of 3 years of experience working with key thought leaders or high influence customers in group practices, academic hospitals, key institutions
- Current account management experience in calling on large Oncology group practices and/or integrated delivery networks
- Strong understanding of the Hematology Oncology therapeutic area and the current Oncology marketplace
- Ability to travel and cover large geography territories
Benefits
- Annual bonuses
- Incentive plans
- Equity awards
- Pension or retirement benefits
- 401(k) company match
- Health and wellness programs
- Fitness centers
- Medical, Dental & Vision
- Life and disability insurance
- Paid time off
- Family support benefits
Company overview
Regeneron Pharmaceuticals is a leading American biotechnology company founded in 1988 and headquartered in Tarrytown, New York. The company specializes in inventing, developing, and commercializing life-transforming medicines for people with serious diseases. Regeneron is renowned for its innovative antibody technologies and has developed several groundbreaking therapies, including EYLEA® for retinal diseases, DUPIXENT® for inflammatory conditions, and the COVID-19 antibody cocktail REGEN-COV®. The company operates with a strong focus on research and development across multiple therapeutic areas including ophthalmology, oncology, cardiovascular diseases, and rare genetic disorders. Regeneron's proprietary VelocImmune® technology platform enables the rapid generation of fully human monoclonal antibodies. With over 15,000 employees globally and annual revenues exceeding $14 billion, Regeneron has established itself as a major force in the biotechnology industry, consistently ranking among the top-performing pharmaceutical companies and maintaining a robust pipeline of investigational therapies.